ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 641

Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis

Ali Duarte-Garcia1, Lihi Eder2, Alisa Stephens-Shields3, Niti Goel4, Maarten de Wit5, Dafna D Gladman6, Oliver FitzGerald7, Philip Helliwell8, Ying Ying Leung9, Philip J. Mease10, Ana-Maria Orbai11, Beverly Shea12, Vibeke Strand13, William Tillett14, Laura C. Coates15 and Alexis Ogdie16, 1Mayo Clinic College of Medicine and Science, Rochester, MN, 2Women's College Research Institute, University of Toronto, Women's College Hospital, Toronto, ON, Canada, 3Department of Biostatistics, University of Pennsylvania, Philadelphia, PA, 4Kezar Life Sciences; Duke University School of Medicine, Durham, NC, 5EULAR standing committee of PARE, Zurich, Switzerland, 6Krembil Research Institute, Toronto Western Hospital, Toronto, ON, Canada, 7Department of Rheumatology, St Vincent's University Hospital and Conway Institute, University College Dublin, Ireland, Dublin, Ireland, 8LIMM, Section of Musculoskeletal Disease, University of Leeds, Leeds, United Kingdom, 9North District Hospital, Hong Kong, China, 10Swedish Medical Center and University of Washington School of Medicine, Seattle, WA, 11Johns Hopkins University School of Medicine, Baltimore, MD, 12University of Ottawa, Ottawa, ON, Canada, 13Stanford University School of Medicine, Palo Alto, CA, 14Royal National Hospital for Rheumatic Diseases and University of Bath, Bath, United Kingdom, 15University of Oxford, Oxford, United Kingdom, 16Medicine/Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: outcome measures and psoriatic arthritis, Validity

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, October 21, 2018

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Joint counts are central to the measurement of musculoskeletal disease activity in psoriatic arthritis (PsA).  Few studies have addressed whether the three most commonly used joint counts: 66/68-Swollen and Tender Joint Counts (SJC66/68TJC), SJC28/TJC28 and SJC76/TJC78, are valid for the measurement of musculoskeletal disease activity. To test the construct validity of the joint counts, we examined the correlations between the joint counts and other variables associated with MSK disease activity. We hypothesized that joint counts would be strongly correlated (rho 0.8-1) with each other, moderately correlated (rho 0.6-0.8) with the physician global assessment (PhGA), and mildly correlated (rho 0.4-0.6) with patient global assessment (PtGA), pain, health assessment questionnaire disability index (HAQ-DI) and C-reactive protein (CRP). 

Methods: Data were requested from 8 phase III randomized controlled trials (RCTs) and the TIght COntrol of Psoriatic Arthritis (TICOPA) trial. A priori, a standardized protocol was designed to study construct validity. Spearman’s correlation coefficients were calculated (all data were skewed/nonparametric) at baseline and the primary endpoint (12-16 weeks for most RCTs, 24 weeks for TICOPA) between the following variables: TJC28, TJC68, TJC78, SJC28, SJC66, SJC78, PtGA, pain, PhGA, HAQ-DI and CRP.  We also calculated Spearman’s correlation coefficients between changes in each of the variables from baseline to follow up.

Results: The SJC28 was moderately to strongly correlated with SJC66 and SJC76 at baseline and follow up and changes in SJC28, SJC66, and SJC76 were moderately correlated (Table).  Similarly, the TJC28 was strongly correlated with TJC68 and TJC78 at both time points as well as among changes in the joint counts between baseline and follow up.  There were mild-to-moderate correlations between SJC and TJC at both time points and similarly changes in joint counts were moderately correlated. The joint counts had low to moderate correlations with PhGA in all three scenarios and correlations with PtGA and pain were low to moderate, depending on the RCT.  Finally, correlations between joint counts and CRP were low in all three scenarios.

Conclusion: These results indicate that SJC and TJC have construct validity and replicated most of the pre-hypothesized relationships with other variables of importance in RCTs. While good correlation between TJC and SJC subsets were identified, the TJC68/SJC66 is recommended by the GRAPPA-OMERACT working group for measurement of peripheral arthritis in PsA.


Disclosure: A. Duarte-Garcia, None; L. Eder, None; A. Stephens-Shields, None; N. Goel, None; M. de Wit, None; D. D. Gladman, None; O. FitzGerald, None; P. Helliwell, AbbVie, Janssen, 2,AbbVie, Amgen, Janssen, Novartis, Pfizer Inc, ucb, 9; Y. Y. Leung, None; P. J. Mease, None; A. M. Orbai, Abbvie, Celgene, Eli Lilly and Company, Horizon, Janssen, Novartis, Pfizer, 2,Eli Lilly and Company, Janssen, Novartis, Pfizer, UCB, 5; B. Shea, None; V. Strand, None; W. Tillett, None; L. C. Coates, None; A. Ogdie, Pfizer, Inc.; Novartis, 2,Abbvie, Amgen, BMS, Corrona, Lilly, Novartis, Pfizer, Takeda, 5.

To cite this abstract in AMA style:

Duarte-Garcia A, Eder L, Stephens-Shields A, Goel N, de Wit M, Gladman DD, FitzGerald O, Helliwell P, Leung YY, Mease PJ, Orbai AM, Shea B, Strand V, Tillett W, Coates LC, Ogdie A. Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/construct-validity-of-the-swollen-and-tender-joint-counts-for-the-measurement-of-msk-disease-activity-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/construct-validity-of-the-swollen-and-tender-joint-counts-for-the-measurement-of-msk-disease-activity-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology